Ledger.Open graph →

SEC Form D · Amendment · filed February 7, 2017

Banyan Biomarkers, Inc

Offering

$12.0M

Sold

$11.4M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

San Diego, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Frederic Sweeney · San Diego, CADirector Darin Glatt · Portland, ORExec Michael Flaherty · Los Angeles, CAExec · Director James B. Kelly · Huntsville, ALExec · Director · Promoter Xiaoqing Xu · Central, Hong KongDirector Heiner Dreismann · Seattle, WAExec Scott Winters · San Rafael, CAExec Ronald Hayes, Ph.D · San Diego, CAExec · Director · Promoter Isaac K. Blech · Cambridge, MAExec · Director Allan Stephan · Seattle, WADirector William Roper, Jr · San Diego, CADirector Will K. Young · Las Vegas, NVDirector Herbert Boyer · San Diego, CADirector David M. Klubert · Huntsville, ALDirector Julie Pashkowsky · San Diego, CAExec Nancy Denslow, Ph.D · San Diego, CADirector Tyler Mckinley · Portland, ORExec · Director William Nelson, Jr · San Rafael, CADirector Jackson Streeter, M.D · San Diego, CAExec · Director Tony Grover · San Diego, CAExec Henry Nordhoff · San Diego, CAExec · Director Dominik M. Aronsky · Huntsville, ALExec Steven Richieri · San Diego, CAExec · Director Peter K. Farrell, Ph.D · Cambridge, MAExec · Director Herbert Boyer · San Diego, CADirector Marcus K. Semones, Ph.D · Cambridge, MAExec · Director Peter B. Finn, Esq · Boston, MAExec · Director Harold Kawaguchi · Seattle, WAExec · Director · Promoter Frederic Sweeney · San Diego, CADirector Andrew Von Eschenbach, M.D · San Diego, CADirector Stanford Warshawsky · San Diego, CADirector Ben Malka · San Rafael, CADirector Stephen Rose · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗